{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:38:53Z","timestamp":1785361133881,"version":"3.55.0"},"reference-count":58,"publisher":"Medknow","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["North Am J Med Sci"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/1947-2714.168657","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T13:15:27Z","timestamp":1461071727000},"page":"421","source":"Crossref","is-referenced-by-count":43,"title":["Dyslipidemia in dermatological disorders"],"prefix":"10.4103","volume":"7","author":[{"given":"ManjunathMala","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetana","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GururajaK","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/1947-2714.168657-1","first-page":"2192","volume-title":"Management of dyslipidemia in adults","author":"Ahmed","year":"1998","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/1947-2714.168657-2","first-page":"99","volume-title":"Prevalence of dyslipidemia in young adult Indian population","author":"Sawant","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/1947-2714.168657-3","first-page":"137","volume-title":"Dyslipidemia in Asian Indians: Determinants and significance","author":"Misra","year":"2004","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/1947-2714.168657-4","first-page":"518","volume-title":"Comorbidities associated with psoriasis - data from the malaysian psoriasis registry","author":"Mazlin","year":"2012","journal-title":"Med J Malaysia"},{"key":"key-10.4103\/1947-2714.168657-5","first-page":"321","volume-title":"A system for phenotyping hyperlipoproteinaemia","author":"Fredrickson","year":"1965","journal-title":"Circulation"},{"key":"key-10.4103\/1947-2714.168657-6","first-page":"297","volume-title":"Metabolic comorbidities and psoriasis","author":"Gisondi","year":"2010","journal-title":"Acta Dermatovenerol Croat"},{"key":"key-10.4103\/1947-2714.168657-7","first-page":"829","volume-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/1947-2714.168657-8","first-page":"486","volume-title":"The association between psoriasis and dyslipidaemia: A systematic review","author":"Ma","year":"2013","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/1947-2714.168657-9","first-page":"1330","volume-title":"The lipid profile in psoriasis: A controlled study","author":"Akhyani","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/1947-2714.168657-10","first-page":"89","volume-title":"Serum lipid abnormalities and psoriasis","author":"Javidi","year":"2007","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/1947-2714.168657-11","first-page":"68","volume-title":"Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/1947-2714.168657-12","first-page":"1","volume-title":"An insight into relationship between psoriasis and metabolic syndrome","author":"Malhotra","year":"2011","journal-title":"EDOJ"},{"key":"key-10.4103\/1947-2714.168657-13","first-page":"353","volume-title":"Prevalence of metabolic syndrome in south Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: A hospital-based case-control study","author":"Madanagobalane","year":"2012","journal-title":"IJD"},{"key":"key-10.4103\/1947-2714.168657-14","first-page":"626","volume-title":"Lichen planus and dyslipidemia: A case-control study","author":"Dreiher","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/1947-2714.168657-15","first-page":"543","volume-title":"Chronic inflammation may explain dyslipidemia in lichen planus patients","author":"Albert","year":"2011","journal-title":"Am J Med"},{"key":"key-10.4103\/1947-2714.168657-16","first-page":"543","volume-title":"Cardiovascular risk factors in patients with lichen planus","author":"Arias-Santiago","year":"2011","journal-title":"Am J Med"},{"key":"key-10.4103\/1947-2714.168657-17","first-page":"1772","volume-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1947-2714.168657-18","first-page":"1418","volume-title":"Pemphigus and dyslipidaemia: A case-control study","author":"Wohl","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/1947-2714.168657-19","first-page":"1131","volume-title":"Dyslipidemia in granuloma annulare: A case-control study","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/1947-2714.168657-20","first-page":"286","volume-title":"Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus","author":"Lagogianni","year":"2005","journal-title":"Clin Biochem"},{"key":"key-10.4103\/1947-2714.168657-21","first-page":"1296","volume-title":"Non-Langerhans cell histiocytoses of the skin","author":"Ansari","year":"2003","journal-title":"Saudi Med J"},{"key":"key-10.4103\/1947-2714.168657-22","first-page":"257","volume-title":"Necrobiotic xanthogranuloma with paraproteinemia","author":"Kossard","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/1947-2714.168657-23","first-page":"634","volume-title":"Sea-blue histiocytosis associated with hyperlipidaemia","author":"Parker","year":"1976","journal-title":"J Clin Pathol"},{"key":"key-10.4103\/1947-2714.168657-24","first-page":"69","volume-title":"The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia","author":"Hahn","year":"2007","journal-title":"J Autoimmun"},{"key":"key-10.4103\/1947-2714.168657-25","first-page":"563","volume-title":"Psoriasis and the metabolic syndrome","author":"Gottleib","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/1947-2714.168657-26","first-page":"61","volume-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case- control study","author":"Naldi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/1947-2714.168657-27","first-page":"430","volume-title":"Lipid peroxidation and antioxidant status in lichen planus","author":"Sezer","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/1947-2714.168657-28","first-page":"800","volume-title":"Oral lichen planus and chronic hepatitis C: A controversial association","author":"de","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/1947-2714.168657-29","first-page":"981","volume-title":"Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne","author":"Bershad","year":"1985","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1947-2714.168657-30","first-page":"625","volume-title":"Retinoids increase human Apo C-III expression at the transcriptional level via the retinoid X receptor.Contribution to the hypertriglyceridemic action of retinoids","author":"Vu-Dac","year":"1998","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1947-2714.168657-31","first-page":"423","volume-title":"Cyclosporine as maintenance therapy in patients with severe psoriasis","author":"Shupack","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/1947-2714.168657-32","first-page":"331","volume-title":"Hyperlipidemia in solid organ transplantation","author":"Kobashigawa","year":"1997","journal-title":"Transplantation"},{"key":"key-10.4103\/1947-2714.168657-33","first-page":"720","volume-title":"Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin A","author":"Derfler","year":"1991","journal-title":"Kidney Int"},{"key":"key-10.4103\/1947-2714.168657-34","first-page":"1012","volume-title":"Cyclosporine, low-density lipoprotein, and cholesterol","author":"de","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/1947-2714.168657-35","first-page":"663","volume-title":"Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients","author":"Apanay","year":"1994","journal-title":"Transplantation"},{"key":"key-10.4103\/1947-2714.168657-36","first-page":"62","volume-title":"Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations","author":"Tory","year":"2009","journal-title":"Transplantation"},{"key":"key-10.4103\/1947-2714.168657-37","first-page":"961","volume-title":"Secondary dyslipidemia.Inadvertent effects of drugs in clinical practice","author":"Henkin","year":"1992","journal-title":"JAMA"},{"key":"key-10.4103\/1947-2714.168657-38","first-page":"930","volume-title":"Heart transplantation - An update","author":"Blum","year":"1996","journal-title":"Clin Cardiol"},{"key":"key-10.4103\/1947-2714.168657-39","first-page":"879","volume-title":"Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient","author":"Kirk","year":"1995","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/1947-2714.168657-40","first-page":"309","volume-title":"The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation","author":"Chan","year":"1981","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1947-2714.168657-41","first-page":"19","volume-title":"Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders","author":"Lenders","year":"1988","journal-title":"Int J Sports Med"},{"key":"key-10.4103\/1947-2714.168657-42","first-page":"1165","volume-title":"Contrasting effects of testosterone and stanozolol on serum lipoprotein levels","author":"Thompson","year":"1989","journal-title":"JAMA"},{"key":"key-10.4103\/1947-2714.168657-43","first-page":"19","volume-title":"Lipid profiles associated with antiretroviral drug choices","author":"van","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.4103\/1947-2714.168657-44","first-page":"49","volume-title":"Dyslipidemia related to antiretroviral therapy","author":"Estrada","year":"2011","journal-title":"AIDS Rev"},{"key":"key-10.4103\/1947-2714.168657-45","first-page":"814","volume-title":"Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis","author":"Kerekes","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/1947-2714.168657-46","unstructured":"Murphy GF, Sellheyer K, Mihm MC. The skin. In: Kumar V, Abbas AK, Fausto N, Eds. Robbins and Cotran Pathologic Basis of Disease. 7 th ed. Philadelphia: Elsevier; 2004: 1248."},{"key":"key-10.4103\/1947-2714.168657-47","unstructured":"Miller M, Vogel RA. Clinical signs and syndromes associated with premature coronary artery disease. In: Miller M, Vogel RA, Eds. The Practice of Coronary Disease Prevention. 8 th ed. Baltimore, Md: Williams & Wilkins; 1996:24-35."},{"key":"key-10.4103\/1947-2714.168657-48","unstructured":"Bolognia JL, Braverman IM. Skin manifestation of internal disease. In: Kasper DL, et al., Eds. Harrison\u2032s Principles of Internal Medicine. 16 th ed. New York: McGraw-Hill; 2005: 296-311."},{"key":"key-10.4103\/1947-2714.168657-49","first-page":"107","volume-title":"Normo lipidemic xanthelasma palpebrarum: Lipid composition, cholesterol metabolism in monocyte-derived macrophages, and plasma lipid peroxidation","author":"Bergman","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/1947-2714.168657-50","first-page":"1799","volume-title":"Xanthoma striatum palmare in a patient with primary biliary cirrhosis and hypercholesterolemia","author":"Hsu","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"key-10.4103\/1947-2714.168657-51","first-page":"44","volume-title":"Eruptive xanthomas as a cutaneous Manifestation of hypertriglyceridemia; A case report","author":"Digby","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"key-10.4103\/1947-2714.168657-52","doi-asserted-by":"crossref","unstructured":"Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.","DOI":"10.1001\/jama.1993.03500230097036"},{"key":"key-10.4103\/1947-2714.168657-53","first-page":"831","volume-title":"Dyslipidemia after kidney transplantation and correlation with cyclosporine level","author":"Hosseini","year":"2013","journal-title":"Nephrourol Mon"},{"key":"key-10.4103\/1947-2714.168657-54","first-page":"613","volume-title":", Adult AIDS Clinical Trials Group Cardiovascular Subcommittee; HIV Medical Association of the Infectious Disease Society of America.Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1947-2714.168657-55","unstructured":"White LE, Horenstein MG, Shea CR. Xanthomas. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulsan I, Eds. Treatment of skin disease. 4 th ed. Elsevier Saunders; 2006: 804."},{"key":"key-10.4103\/1947-2714.168657-56","first-page":"171","volume-title":"Lipid management in children","author":"Zappalla","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/1947-2714.168657-57","first-page":"98","volume-title":"Statins and the skin","author":"Dobritoiu","year":"2011","journal-title":"Ther Pharmacol Clin Toxicol"},{"key":"key-10.4103\/1947-2714.168657-58","first-page":"598","volume-title":"Recommendations for severe hypertriglyceridemia treatment, are there new strategies?","author":"Filippatos","year":"2014","journal-title":"Curr Vasc Pharmacol"}],"container-title":["North American Journal of Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:17:00Z","timestamp":1498303020000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.najms.org\/text.asp?2015\/7\/10\/421\/168657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"alternative-id":["168657"],"URL":"https:\/\/doi.org\/10.4103\/1947-2714.168657","relation":{},"ISSN":["1947-2714"],"issn-type":[{"value":"1947-2714","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}